Gene, Stem Cell, and Alternative Therapies for SCA 1
Spinocerebellar ataxia 1 is an autosomal dominant disease characterized by neurodegeneration and motor dysfunction. In disease pathogenesis, polyglutamine expansion within Ataxin-1, a gene involved in transcriptional repression, causes protein nuclear inclusions to form. Most notably, neuronal dysfu...
Main Authors: | Jacob Lewis Wagner, Deirdre Margaret O'Connor, Anthony Donsante, Nicholaus M Boulis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-08-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2016.00067/full |
Similar Items
-
A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD
by: Pawel M. Switonski, et al.
Published: (2015-01-01) -
Combined overexpression of ATXN1L and mutant ATXN1 knockdown by AAV rescue motor phenotypes and gene signatures in SCA1 mice
by: Carrell, E.M, et al.
Published: (2022) -
RNAi or overexpression: Alternative therapies for Spinocerebellar Ataxia Type 1
by: Megan S. Keiser, et al.
Published: (2013-08-01) -
Pathogenesis of SCA3 and implications for other polyglutamine diseases
by: Hayley S. McLoughlin, et al.
Published: (2020-02-01) -
Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation
by: An-Hsun Chou, et al.
Published: (2008-07-01)